When using criteria other than CQ category, a CQ holder may be listed multiple times. This indicates the CQ holder is associated with multiple categories. Further narrow the search by using the CQ category drop down menu.
Note that CQ holders with limitations are indicated. Where no limitation is listed, there is none.
Filter(s)
Maria A Abadi, M.D.
Chappaqua, NY 10514
Cytopathology
Maria A Abadi, M.D.
Chappaqua, NY 10514
Histopathology General
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Bacteriology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Blood pH and Gases
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Clinical Chemistry
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Clinical Toxicology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Cytopathology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Diagnostic Immunology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Endocrinology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Hematology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Histopathology General
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Immunohematology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Mycology (limited to yeast identification by conventional methods and Cryptococcus antigen detection)
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Parasitology
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Transfusion Services
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Ther. Sub. Mon./Quant. Tox.
Rakesh K Abbi, M.D.
Chappaqua, NY 10514
Virology (limited to FDA-approved antigen detection and FDA-approved molecular methods)
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Cellular Immunology Malignant Leukocyte Immunophenotyping
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Cellular Immunology Non-Malignant Leukocyte Immunophenotyping
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Cytopathology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Diagnostic Immunology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Genetic Testing (limited to molecular pathology)
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Hematology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Histopathology General
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Immunohematology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Mycobacteriology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Mycology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Oncology Molecular and Cellular Tumor Markers
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Parasitology
Dalia Abdel Azim, M.D., Ph.D.
Stamford, CT 06903
Virology (limited to antigen detection and molecular methods)
Zahidur R Abedin, Ph.D.
Philadelphia, PA 19119
Genetic Testing (limited to molecular for inherited colorectal cancer)
Zahidur R Abedin, Ph.D.
Philadelphia, PA 19119
Oncology Molecular and Cellular Tumor Markers
Zahidur R Abedin, Ph.D.
Philadelphia, PA 19119
Virology (limited to molecular methods for respiratory viruses)
Dvorah Abeliovich, Ph.D.
Jerusalem, 93589
Genetic Testing (limited to molecular)
Gyorgy A Abel, M.D., Ph.D.
Carlisle, MA 01741
Virology
Avinash V Abhyankar, Ph.D.
Plainsboro, NJ 08536
Genetic Testing (limited to molecular)
Fatima E Abidi, Ph.D.
Greenwood, SC 29646
Genetic Testing (limited to molecular)
John M Abran, M.D.
Palo Alto, CA 94301
Cytopathology
John M Abran, M.D.
Palo Alto, CA 94301
Histopathology General
John M Abran, M.D.
Palo Alto, CA 94301
Oncology Molecular and Cellular Tumor Markers
Amer K. Abu Alfa, M.D.
South Burlington, VT 05403
Histopathology General
Ntei Abudu, Ph.D.
Durham, NC 27703
Clinical Chemistry (limited to specimen validity for drug testing)
Ntei Abudu, Ph.D.
Durham, NC 27703
Clinical Toxicology
Ntei Abudu, Ph.D.
Durham, NC 27703
Forensic Toxicology
Bodhraj Acharya, Ph.D.
Chittenango, NY 13037
Clinical Chemistry (limited to FDA-approved methods and soluble tumor marker testing)
Bodhraj Acharya, Ph.D.
Chittenango, NY 13037
Clinical Toxicology (limited to initial/qualitative testing only)
Bodhraj Acharya, Ph.D.
Chittenango, NY 13037
Diagnostic Immunology
Bodhraj Acharya, Ph.D.
Chittenango, NY 13037
Endocrinology (limited to FDA-approved methods)
Bodhraj Acharya, Ph.D.
Chittenango, NY 13037
Hematology
Scott M Acker, M.D.
Marietta, GA 30064
Bacteriology
Scott M Acker, M.D.
Marietta, GA 30064
Cytopathology
Scott M Acker, M.D.
Marietta, GA 30064
Histopathology General
Scott M Acker, M.D.
Marietta, GA 30064
Mycology
Scott M Acker, M.D.
Marietta, GA 30064
Virology (limited to FDA-approved molecular methods for SARS-CoV-2)
Wendy R Adams, Ph.D.
Doylestown, PA 18902
Clinical Toxicology
Wendy R Adams, Ph.D.
Doylestown, PA 18902
Forensic Toxicology
Wendy R Adams, Ph.D.
Doylestown, PA 18902
Ther. Sub. Mon./Quant. Tox.
Tatyana Adayev, Ph.D.
Staten Island, NY 10306
Genetic Testing (limited to Fragile X syndrome)
Martin E Adelson, Ph.D.
East Windsor, NJ 08520
Bacteriology (limited to molecular methods and susceptibility testing)
Martin E Adelson, Ph.D.
East Windsor, NJ 08520
Diagnostic Immunology
Martin E Adelson, Ph.D.
East Windsor, NJ 08520
Mycology (limited to molecular detection and yeast antifungal susceptibility testing following CLSI guidelines)
Martin E Adelson, Ph.D.
East Windsor, NJ 08520
Parasitology (limited to molecular methods)
Martin E Adelson, Ph.D.
East Windsor, NJ 08520
Virology (limited to molecular methods)
Oluwatobi Adelaja, M.D.
Hoffman Estates, IL 60169
Histopathology General
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Bacteriology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Blood pH and Gases
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Clinical Chemistry
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Clinical Toxicology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Diagnostic Immunology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Endocrinology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Genetic Testing (limited to molecular pathology)
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Hematology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Immunohematology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Mycobacteriology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Mycology
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Oncology Molecular and Cellular Tumor Markers
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Parasitology (limited to blood-borne parasites)
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Transfusion Services
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Ther. Sub. Mon./Quant. Tox.
Patricia V Adem, M.D.
Lincoln Park, NJ 07035
Virology (limited to FDA-approved methods in direct antigen detection and FDA-approved molecular methods)
Adebowale J Adeniran, M.D.
Seymour, CT 06483
Bacteriology (limited to molecular detection of CT/NG)
Adebowale J Adeniran, M.D.
Seymour, CT 06483
Cytopathology
Adebowale J Adeniran, M.D.
Seymour, CT 06483
Histopathology General
Adebowale J Adeniran, M.D.
Seymour, CT 06483
Virology (limited to FDA-approved molecular HPV tests)
Debasis Adhikari, M.D.
Syosset, NY 11791
Cytopathology
Debasis Adhikari, M.D.
Syosset, NY 11791
Histopathology General
Opoku Adjapong, M.D.
Watertown, NY 13601
Cytopathology
Opoku Adjapong, M.D.
Watertown, NY 13601
Histopathology General
Opoku Adjapong, M.D.
Watertown, NY 13601
Immunohematology
Opoku Adjapong, M.D.
Watertown, NY 13601
Transfusion Services
Esther H Adler, M.D.
Teaneck, NJ 07666
Bacteriology
Esther H Adler, M.D.
Teaneck, NJ 07666
Blood pH and Gases
Esther H Adler, M.D.
Teaneck, NJ 07666
Clinical Chemistry
Esther H Adler, M.D.
Teaneck, NJ 07666
Cytopathology
Esther H Adler, M.D.
Teaneck, NJ 07666
Diagnostic Immunology
Esther H Adler, M.D.
Teaneck, NJ 07666
Endocrinology
Esther H Adler, M.D.
Teaneck, NJ 07666
Hematology
Esther H Adler, M.D.
Teaneck, NJ 07666
Histopathology General
Esther H Adler, M.D.
Teaneck, NJ 07666
Immunohematology
Esther H Adler, M.D.
Teaneck, NJ 07666
Mycobacteriology